Look Who's Speaking in Portland! Get an early glimpse of what's in store for you in Portland, Oregon at this year’s CRS Annual Meeting & Exposition. CRS offers a distinguished line-up of:

• Plenary Speakers
• Mini-Symposia
• and Scientific Sessions in Bioactive Materials, Consumer & Diversified Products, and Veterinary.

For more information, please Contact CRS.

www.controlledrelease.org/meeting

The Pharma CI Conference & Exhibition is truly the largest and best gathering of senior level pharma, biotech, medical device, and diagnostic executives in competitive/business intelligence with 300 attendees. See the list on our website.

Building on the momentum of last year's historic, sold out event, the 2010 Pharma CI Conference is on track for even more success. This event is known for impactful networking for everyone who attends because we truly bring together all the intelligence industry's heavy hitters under one roof. The "who's who" will all be there.

To register, or for more information, please call +1 212 228 7974 / +1 713 398 6888 or visit:

www.pharmaciconference.com.

PDA’s parenterals conference is a must-attend for everyone working on sterile dosage forms. It will give a comprise overview of current trends of parenteral manufacturing in the industry, innovations in equipment and process technology, and the practical impact of new regulatory guidances, especially ICH Q8, Q9 and Q10.

Highlights of the conference will cover:

• Production environments and their control
• Components and impact of quality including packaging, tolerance for defects, glass breakage, ready-to-use and ready-to-sterilize
• Manufacturing including parametric release, total process control, high speed automation, in-line testing, knowledge management, continual improvement, single-use systems
• Innovative manufacturing facilities including production planning (push/pull, flexibility), dedicated, single and multipurpose facilities
• Isolators and RABS, and current industry trends • Impact of recent regulatory guidances, especially ICH Q8, Q9 & Q10, variations, FDA guidances; PIC/S Annex 1 interpretation; dedicated facilities; Inspection trends; EU GMP Annex 1

To register, or for more information, please call PDA on: +49 (0) 33056-237710, email info-europe@pda.org or visit:

www.pda.org/Parenteral2010

The RDD Europe 2011 meeting format will include:

• In-depth discussions of many developing issues surrounding aerosol drug delivery including new therapeutic opportunities and drug design technologies, progress in drug development alongside novel in vitro and in vivo testing methods, regulatory science..... and much more.
• Scientific Poster Sessions covering all aspects of regulatory science, formulation development, new research methods and advanced drug delivery technologies.
• Technology Exhibition in which excipient, device and equipment designers plus component and service suppliers present their latest developments in a table top format.
• Workshop Sessions featuring practical and interactive demonstrations of innovative technologies, products and services.

For more information, please Contact RDD Online

www.rddonline.com/rdd/rdd.php?id=5&sid=1